Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Cipla
Medtronic
Covington
UBS
Federal Trade Commission
Harvard Business School
Deloitte
Novartis
Colorcon

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,482,934

« Back to Dashboard

Summary for Patent: 5,482,934
Title: Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions
Abstract:The present invention relates to compounds of the formula: ##STR1## in which X.sub.1 and X.sub.2 correspond to H or F without distinction; R.sub.1 represents the following radicals: ##STR2## and R.sub.2 represents the radicals ##STR3## in the form of an R epimer, an S epimer, or a stereoisomeric mixture of the R and S epimers in terms of the orientation of the substituents on the carbon atom at position 22, novel intermediates and a method of their preparation by hydrolysis-ketalization, and use of such compounds as drugs and/or therapeutic agents.
Inventor(s): Calatayud; Jose (Madrid, ES), Conde; Jose R. (Madrid, ES), Luna; Manuel (Madrid, ES)
Assignee: Especialidades Latinas Medicamentos Universales, S.A. (Elmu, S.A.) (Madrid, ES)
Application Number:08/278,112
Patent Claim Types:
see list of patent claims
Compound; Use; Composition; Dosage form;

Drugs Protected by US Patent 5,482,934

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Astrazeneca Pharms ALVESCO ciclesonide AEROSOL, METERED;INHALATION 021658-002 Jan 10, 2008 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y METHOD OF TREATING INFLAMMATORY CONDITIONS ➤ Subscribe
Astrazeneca Pharms ALVESCO ciclesonide AEROSOL, METERED;INHALATION 021658-003 Jan 10, 2008 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y METHOD OF TREATING INFLAMMATORY CONDITIONS ➤ Subscribe
Astrazeneca Pharms ZETONNA ciclesonide AEROSOL, METERED;NASAL 202129-001 Jan 20, 2012 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y METHOD OF TREATING INFLAMMATORY CONDITIONS ➤ Subscribe
Astrazeneca Pharms OMNARIS ciclesonide SPRAY, METERED;NASAL 022004-001 Oct 20, 2006 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y NASAL TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,482,934

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany 122005000030 ➤ Subscribe
Spain 2034893 ➤ Subscribe
France 2666585 ➤ Subscribe
United Kingdom 9118967 ➤ Subscribe
Canada 2050812 ➤ Subscribe
Switzerland 683343 ➤ Subscribe
Germany 4129535 ➤ Subscribe
Brazil 1100860 ➤ Subscribe
Belgium 1005876 ➤ Subscribe
United Kingdom 2247680 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Cipla
Chubb
Queensland Health
Boehringer Ingelheim
Mallinckrodt
Fuji
Medtronic
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot